The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

88 articles for AP Ijzerman


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and evaluation of N-substituted 2-amino-4,5-diarylpyrimidines as selective adenosine AEBI
Leiden University
5'-Substituted Amiloride Derivatives as Allosteric Modulators Binding in the Sodium Ion Pocket of the Adenosine A2A Receptor.EBI
Leiden University
Structure-kinetics relationships of Capadenoson derivatives as adenosine A1 receptor agonists.EBI
Leiden University
Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.EBI
University of Ferrara
Structure-Affinity Relationships (SARs) and Structure-Kinetics Relationships (SKRs) of Kv11.1 Blockers.EBI
Leiden University
When structure-affinity relationships meet structure-kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists.EBI
Leiden University
Design and synthesis of novel small molecule CCR2 antagonists: evaluation of 4-aminopiperidine derivatives.EBI
TBA
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.EBI
University of Ferrara
Agonists for the adenosine A1 receptor with tunable residence time. A Case for nonribose 4-amino-6-aryl-5-cyano-2-thiopyrimidines.EBI
Leiden University
Quantitative evaluation of the beta 2-adrenoceptor intrinsic activity of N-tert-butylphenylethanolamines.EBI
TBA
Structure-based identification of OATP1B1/3 inhibitors.EBI
Ku Leuven
Structure-kinetic relationships--an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as chemokine receptor 2 antagonists.EBI
Leiden University
Strategies to reduce HERG K+ channel blockade. Exploring heteroaromaticity and rigidity in novel pyridine analogues of dofetilide.EBI
Leiden University
Synthesis and evaluation of homo-bivalent GnRHR ligands.EBI
Leiden University
A steric and electrostatic comparison of three models for the agonist/antagonist binding site on the adenosine A1 receptor.EBI
Center For Bio-Pharmaceutical Sciences
Quantitative evaluation of the beta 2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines.EBI
TBA
Identifying novel adenosine receptor ligands by simultaneous proteochemometric modeling of rat and human bioactivity data.EBI
Leiden/Amsterdam Center For Drug Research
A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design.EBI
Radboud University Nijmegen Medical Centre
2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.EBI
Leiden/Amsterdam Center For Drug Research
Luteolin, a compound with adenosine A(1) receptor-binding activity, and chromone and dihydronaphthalenone constituents from Senna siamea.EBI
Leiden University
Synthesis and evaluation of homodimeric GnRHR antagonists having a rigid bis-propargylated benzene core.EBI
Leiden University
A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.EBI
Leiden/Amsterdam Center For Drug Research
A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor.EBI
Leiden/Amsterdam Center For Drug Research
Inhibition of nucleoside transport proteins by C8-alkylamine-substituted purines.EBI
Leiden University
New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine.EBI
University of Leiden
N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.EBI
Leiden University
Pyrazole derivatives as partial agonists for the nicotinic acid receptor.EBI
Leiden/Amsterdam Center For Drug Research
2,5'-Disubstituted adenosine derivatives: evaluation of selectivity and efficacy for the adenosine A(1), A(2A), and A(3) receptor.EBI
Leiden/Amsterdam Center For Drug Research
Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.EBI
Vrije Universiteit
5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.EBI
Leiden/Amsterdam Center For Drug Research
N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A(1) adenosine receptor.EBI
University of Camerino
N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.EBI
Leiden/Amsterdam Center For Drug Research
5'-N-substituted carboxamidoadenosines as agonists for adenosine receptors.EBI
Leiden University
5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor.EBI
Leiden/Amsterdam Center For Drug Research
N6-cyclopentyl-3'-substituted-xylofuranosyladenosines: a new class of non-xanthine adenosine A1 receptor antagonists.EBI
University of Ghent
N6,C8-distributed adenosine derivatives as partial agonists for adenosine A1 receptors.EBI
Leiden/Amsterdam Center For Drug Research
Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor.EBI
Leiden University
1H-imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists.EBI
Center For Bio-Pharmaceutical Sciences
Synthesis and use of FSCPX, an irreversible adenosine A1 antagonist, as a 'receptor knock-down' tool.EBI
Vrije Universiteit
2-Nitro analogues of adenosine and 1-deazaadenosine: synthesis and binding studies at the adenosine A1, A2A and A3 receptor subtypes.EBI
University of Amsterdam
Structure-activity relationships of trans-substituted-propenoic acid derivatives on the nicotinic acid receptor HCA2 (GPR109A).EBI
Leiden University
Hybrid ortho/allosteric ligands for the adenosine A(1) receptor.EBI
Leiden University
Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.EBI
The Scripps Research Institute
A series of 2,4-disubstituted quinolines as a new class of allosteric enhancers of the adenosine A3 receptor.EBI
Leiden University
Substituted terphenyl compounds as the first class of low molecular weight allosteric inhibitors of the luteinizing hormone receptor.EBI
Leiden University
Novel 2- and 4-substituted 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric modulators of the A3 adenosine receptor.EBI
National Institute of Diabetes and Digestive and Kidney Diseases
False positives in a reporter gene assay: identification and synthesis of substituted N-pyridin-2-ylbenzamides as competitive inhibitors of firefly luciferase.EBI
Leiden/Amsterdam Center For Drug Research
Interference of linoleic acid fraction in some receptor binding assays.EBI
Leiden University
2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.EBI
Leiden/Amsterdam Center For Drug Research
Structure-activity relationships of new 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric enhancers of the A3 adenosine receptor.EBI
Leiden University
2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.EBI
Leiden/Amsterdam Center For Drug Research
Development of subtype-selective covalent ligands for the adenosine AEBI
Leiden University
2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.EBI
Leiden/Amsterdam Center For Drug Research
Inhibition of nucleoside transport by new analogues of 4-nitrobenzylthioinosine: replacement of the ribose moiety by substituted benzyl groups.EBI
Leiden University
Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine AEBI
Leiden University
Synthesis and biological evaluation of 2,3,5-substituted [1,2,4]thiadiazoles as allosteric modulators of adenosine receptors.EBI
Leiden University
Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2.EBI
Leiden Academic Centre For Drug Research
Targeting the KEBI
Leiden University
Pyrido[2,1-f]purine-2,4-dione derivatives as a novel class of highly potent human A(3) adenosine receptor antagonists.EBI
Instituto De QuíMica MéDica (Csic)
5'-Deoxy congeners of 9-(3-amido-3-deoxy-beta-D-xylofuranosyl)-N(6)-cyclopentyladenine: new adenosine A(1) receptor antagonists and inverse agonists.EBI
Ghent University
Substituted 4-phenyl-2-(phenylcarboxamido)-1,3-thiazole derivatives as antagonists for the adenosine A(1) receptor.EBI
Leiden/Amsterdam Center For Drug Research
Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A(3) receptor.EBI
Vrije Universiteit
Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge Strength.EBI
Heptares Therapeutics
Allosteric modulation of the adenosine A(1) receptor. Synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding.EBI
Leiden/Amsterdam Center For Drug Research
Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine AEBI
Leiden University
Pyrrolone Derivatives as Intracellular Allosteric Modulators for Chemokine Receptors: Selective and Dual-Targeting Inhibitors of CC Chemokine Receptors 1 and 2.EBI
Leiden University
A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds.EBI
Vrije Universiteit
A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives.EBI
Vrije Universiteit
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.EBI
National Institute of Diabetes
Synthesis and Pharmacological Evaluation of Triazolopyrimidinone Derivatives as Noncompetitive, Intracellular Antagonists for CC Chemokine Receptors 2 and 5.EBI
Leiden University
5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.EBI
Solvay Pharma
Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization.EBI
Leiden University
Synthesis and biological evaluation of negative allosteric modulators of the Kv11.1(hERG) channel.EBI
Leiden University
Affinity and kinetics study of anthranilic acids as HCA2 receptor agonists.EBI
Leiden University
Removal of human ether-à-go-go related gene (hERG) K+ channel affinity through rigidity: a case of clofilium analogues.EBI
Leiden University
N4-unsubstituted N1-arylpiperazines as high-affinity 5-HT1A receptor ligands.EBI
Solvay Duphar Research Laboratories
Synthesis and biological evaluation of a new series of 2,3,5-substituted [1,2,4]-thiadiazoles as modulators of adenosine A1 receptors and their molecular mechanism of action.EBI
Leiden/Amsterdam Center For Drug Research
An Affinity-Based Probe for the Human Adenosine AEBI
Astrazeneca
A model for the antagonist binding site on the adenosine A1 receptor, based on steric, electrostatic, and hydrophobic properties.EBI
Center For Bio-Pharmaceutical Sciences
Discovery and Kinetic Profiling of 7-Aryl-1,2,4-triazolo[4,3-a]pyridines: Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2.EBI
Leiden University
Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718.EBI
Center For Bio-Pharmaceutical Sciences
Structure-Affinity Relationships and Structure-Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists.EBI
Leiden University
Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine AEBI
Leiden University
S1P receptors modulators and their use thereofBDB
Akaal Pharma
Design, synthesis and biological evaluation of CB1 cannabinoid receptor ligands derived from the 1,5-diarylpyrazole scaffold.BDB
Nanchang University School of Pharmaceutical Science
Rationally designed sulfamides as glutamate carboxypeptidase II inhibitors.BDB
Washington State University At Pullman
Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonist.BDB
Pfizer
Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines.BDB
Astrazeneca